Cerebral Hemorrhage Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Cerebral Hemorrhage clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

HypertensionStrokeIntracerebral Hemorrhage
Zeenat Qureshi Stroke Institute1,000 enrolled9 locationsNCT06402968
Recruiting

Augmented Renal Clearance in Neurocritical Care

Ischemic StrokeIntracerebral HemorrhageTBI (Traumatic Brain Injury)+4 more
University of Alberta512 enrolled3 locationsNCT07410624
Recruiting
Phase 3

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Atrial FibrillationIntracerebral Hemorrhage
Yale University700 enrolled184 locationsNCT03907046
Recruiting
Not Applicable

MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors

HypertensionIntracerebral Hemorrhage
The University of Hong Kong140 enrolled1 locationNCT05830305
Recruiting
Not Applicable

Neurologic Stem Cell Treatment Study

Cognitive ImpairmentDementiaTraumatic Brain Injury+23 more
MD Stem Cells500 enrolled3 locationsNCT02795052
Recruiting

Mechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage

Heart FailureAtrial FibrillationArrhythmias, Cardiac+9 more
Beijing Tiantan Hospital1,000 enrolled1 locationNCT06906432
Recruiting
Phase 3

Avoiding Anticoagulation After IntraCerebral Haemorrhage

Atrial FibrillationIntracerebral HemorrhageMicrohaemorrhage
University Hospital, Lille300 enrolled3 locationsNCT03243175
Recruiting
Phase 3

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

DeathAtrial FibrillationChronic Kidney Diseases+6 more
Region Stockholm1,400 enrolled34 locationsNCT05679024
Recruiting

Cerebrovascular Disease: Quality of Life (CODE: QoL)

Quality of LifeStressCaregiver Burden+7 more
University of Zurich680 enrolled1 locationNCT06443268
Recruiting

Registry of Multicenter Brain-Heart Comorbidity in China

Heart FailureAtrial FibrillationCardiac Arrest+10 more
Beijing Tiantan Hospital100,000 enrolled14 locationsNCT05961748
Recruiting

Prospective Cohort Study of Intracerebral Hemorrhage

Intracerebral Hemorrhage
Second Affiliated Hospital, School of Medicine, Zhejiang University856 enrolled1 locationNCT04707105